Cardiogenic shock (CS) remains the most common cause of death in patients admitted with
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …

Variants in> 12 genes encoding sarcomeric proteins can cause various cardiomyopathies.
The two most common are hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

Background Acute kidney injury (AKI) in the intensive care unit is associated with significant
mortality and morbidity. Objectives To determine and update previous recommendations for …

Methods ADQI (Acute Disease Quality Initiative) is an ongoing process that produces
evidence‐based recommendations on the diagnosis, prevention, and management of AKI …

Background Acute left ventricular dysfunction is a major complication of cardiac surgery and
is associated with increased mortality. Meta-analyses of small trials suggest that …

Levosimendan was first approved for clinical use in 2000, when authorization was granted
by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely …

The invention of CPB revolutionized cardiac surgery. This vital tool has been continuously
refined over the years. Today, achieving excellent results depends on a team approach and …

Acute kidney injury (AKI) is a major medical problem that is of particular concern after
cardiac surgery. Perioperative AKI is independently associated with an increase in short …

Acute heart failure (HF) and in particular, cardiogenic shock are associated with high
morbidity and mortality. A therapeutic dilemma is that the use of positive inotropic agents …